The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants. By comparing younger to older participants enrolled in a HIV vaccine efficacy trial, we aimed to gain insights into the inclusion of adolescents in future trials. This was a sub-analysis of a multisite HIV vaccine randomized clinical trial in South Africa, conducted January-September 2007. Motivations for trial enrolment, social harms, adverse events and loss to follow-up were compared between younger (18-20 years old) and older participants (21-35 years old).
GlobalResearch at UCSF presents the broad scope of health research that is being conducted by UCSF researchers worldwide